drugset / Trial / NCT00707902

Clinical Trial for Assessment of Safety and Efficacy of a Echinacea/Sage Spray Compared to a Chlorhexidine/Lidocaine Spray in the Treatment of Acute Sore Throats

NCT00707902 ↗

Phase 3 Completed 154 enrolled A. Vogel AG
RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the study is to show non-inferiority of an echinacea/sage spray compared to a chlorhexidine/lidocaine-spray in the treatment of acute sore throat during five days of treatment. Main outcome parameter is the non-inferiority in number of responders between the two treatment groups. A responder is defined as a reduction by 50% of the total baseline score taken prior to treatment start. The symptoms are assessed with a symptom score.

Timeline

Start
2006-02
Primary completion
—
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator chlorhexidine/lidocaine Unknown — Other
Comparator echinacea/sage Unknown — Other

Indications